285 related articles for article (PubMed ID: 33832410)
1. Current opinion on risk assessment of cosmetics.
Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
[TBL] [Abstract][Full Text] [Related]
2. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
[TBL] [Abstract][Full Text] [Related]
3. Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019.
Gustafson E; Debruyne C; De Troyer O; Rogiers V; Vinken M; Vanhaecke T
Arch Toxicol; 2020 Nov; 94(11):3723-3735. PubMed ID: 32839844
[TBL] [Abstract][Full Text] [Related]
4. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
[TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment?
Kalicińska J; Wiśniowska B; Polak S; Spiewak R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047774
[TBL] [Abstract][Full Text] [Related]
6. Beyond dermal exposure: The respiratory tract as a target organ in hazard assessments of cosmetic ingredients.
Thá EL; Canavez ADPM; Schuck DC; Gagosian VSC; Lorencini M; Leme DM
Regul Toxicol Pharmacol; 2021 Aug; 124():104976. PubMed ID: 34139277
[TBL] [Abstract][Full Text] [Related]
7. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
8. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
9. Safety assessment of personal care products/cosmetics and their ingredients.
Nohynek GJ; Antignac E; Re T; Toutain H
Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
[TBL] [Abstract][Full Text] [Related]
10. Safety Assessment of Panax spp Root-Derived Ingredients as Used in Cosmetics.
Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
Int J Toxicol; 2015; 34(3 Suppl):5S-42S. PubMed ID: 26684797
[TBL] [Abstract][Full Text] [Related]
11. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
Almeida A; Sarmento B; Rodrigues F
Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
[TBL] [Abstract][Full Text] [Related]
12. Continuing animal tests on cosmetic ingredients for REACH in the EU.
Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
[TBL] [Abstract][Full Text] [Related]
13. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
14. Safety Assessment of PEGs Cocamine and Related Ingredients as Used in Cosmetics.
Boyer I; Burnett CL; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
Int J Toxicol; 2018; 37(2_suppl):10S-60S. PubMed ID: 30235961
[TBL] [Abstract][Full Text] [Related]
15. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
[TBL] [Abstract][Full Text] [Related]
16. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
17. Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients.
Vinken M; Pauwels M; Ates G; Vivier M; Vanhaecke T; Rogiers V
Arch Toxicol; 2012 Mar; 86(3):405-12. PubMed ID: 22038139
[TBL] [Abstract][Full Text] [Related]
18. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
;
Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
[TBL] [Abstract][Full Text] [Related]
19. Amended final report on the safety assessment of Oryza Sativa (rice) Bran Oil, Oryza Sativa (rice) Germ Oil, Rice Bran Acid,Oryza Sativa (rice) Bran Wax, Hydrogenated Rice Bran Wax, Oryza Sativa (rice)Bran Extract, Oryza Sativa (rice) Extract, Oryza Sativa (rice) Germ Powder, Oryza Sativa (rice) Starch, Oryza Sativa (rice) Bran, Hydrolyzed Rice Bran Extract, Hydrolyzed Rice Bran Protein, Hydrolyzed Rice Extract, and Hydrolyzed Rice Protein.
Int J Toxicol; 2006; 25 Suppl 2():91-120. PubMed ID: 17090480
[TBL] [Abstract][Full Text] [Related]
20. Amended Safety Assessment of Parabens as Used in Cosmetics.
Cherian P; Zhu J; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B
Int J Toxicol; 2020; 39(1_suppl):5S-97S. PubMed ID: 32723119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
